Explore groundbreaking research on pancreatic cancer treatment that shows promise in inducing complete tumour regression.

Combination therapies represent a promising frontier in cancer treatment, addressing the critical need to enhance efficacy ...

Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory ...

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer. The study shows that a combination of ...

A specific genetic alteration, known as an ALK fusion, drives non-small cell lung cancer in some patients. This abnormality leads to excessive activity of the ALK protein, a key cancer promoter. These ...

Although treatment for cancers has significantly improved since the birth of chemotherapy almost a century ago, many patients still experience therapeutic resistance and develop recurrence.